Levofloxacin (Page 16 of 16)

PRINCIPAL DISPLAY PANEL

TO OPEN — TEAR AT NOTCH
ONE UNIT
LEVOFLOXACIN INJECTION
in 5% Dextrose
250 mg in 50 mL 5% Dextrose (5 mg/mL)
FOR INTRAVENOUS INFUSION
INFUSE OVER 60 MINUTES
LEAVE BAG IN OVERWRAP UNTIL USE.
PHARMACIST: Dispense the accompanying
Medication Guide to each patient.
Each 50 mL contains a dilute solution equivalent of 250 mg of Levofloxacin, USP
(5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium
Hydroxide, NF to adjust pH to 3.8-5.8.
USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below
25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the
product. Protect from light. Avoid excessive heat and protect from freezing.
Single dose container. Additives should not be added or infused through
the same intravenous line. The overwrap is a moisture barrier. Do not remove
unit from overwrap until ready to use. Use unit promptly when pouch is open.
After removing the overwrap, check for minute leaks by squeezing container
firmly. If leaks are found, discard unit as sterility may be impaired. Use only
if solution is clear and container is undamaged. DISCARD UNUSED
PORTION. Must not be used in series connections.
Rx OnlyNDC 0143-9722-01

TO OPEN -- TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 250 mg in 50 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 60 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 50 mL contains a dilute solution equivalent of 250 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9722-01
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

TO OPEN — TEAR AT NOTCH
ONE UNIT
LEVOFLOXACIN INJECTION
in 5% Dextrose
500 mg in 100 mL 5% Dextrose (5 mg/mL)
FOR INTRAVENOUS INFUSION
INFUSE OVER 60 MINUTES
LEAVE BAG IN OVERWRAP UNTIL USE.
PHARMACIST: Dispense the accompanying
Medication Guide to each patient.
Each 100 mL contains a dilute solution equivalent of 500 mg of Levofloxacin, USP (5 mg/mL) in
5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to
3.8-5.8.
USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF);
however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from
light. Avoid excessive heat and protect from freezing.
Single dose container. Additives should not be added or infused through the same intravenous
line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use.
Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by
squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only
if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not
be used in series connections.
Rx OnlyNDC 0143-9721-01

TO OPEN -- TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 60 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 100 mL contains a dilute solution equivalent of 500 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9721-01
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

TO OPEN — TEAR AT NOTCH
ONE UNIT
LEVOFLOXACIN INJECTION
in 5% Dextrose
750 mg in 150 mL 5% Dextrose (5 mg/mL)
FOR INTRAVENOUS INFUSION
INFUSE OVER 90 MINUTES
LEAVE BAG IN OVERWRAP UNTIL USE.
PHARMACIST: Dispense the accompanying
Medication Guide to each patient.
Each 150 mL contains a dilute solution equivalent of 750 mg
of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain
Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust
pH to 3.8-5.8.
USUAL ADULT DOSAGE: See package insert. Recommended
storage: at or below 25ºC (77ºF); however, brief exposure up to
40ºC (104ºF) does not adversely affect the product. Protect from
light. Avoid excessive heat and protect from freezing.
Single dose container. Additives should not be added or
infused through the same intravenous line. The overwrap is
a moisture barrier. Do not remove unit from overwrap until
ready to use. Use unit promptly when pouch is open. After
removing the overwrap, check for minute leaks by squeezing
container firmly. If leaks are found, discard unit as sterility may
be impaired. Use only if solution is clear and container is
undamaged. DISCARD UNUSED PORTION. Must not be
used in series connections.
Rx OnlyNDC 0143-9720-01

TO OPEN -- TEAR AT NOTCH ONE UNIT LEVOFLOXACIN INJECTION in 5% Dextrose 750 mg in 150 mL 5% Dextrose (5 mg/mL) FOR INTRAVENOUS INFUSION INFUSE OVER 90 MINUTES LEAVE BAG IN OVERWRAP UNTIL USE. PHARMACIST: Dispense the accompanying Medication Guide to each patient. Each 150 mL contains a dilute solution equivalent of 750 mg of Levofloxacin, USP (5 mg/mL) in 5% dextrose. May contain Hydrochloric Acid, NF and/or Sodium Hydroxide, NF to adjust pH to 3.8-5.8. USUAL ADULT DOSAGE: See package insert. Recommended storage: at or below 25ºC (77ºF); however, brief exposure up to 40ºC (104ºF) does not adversely affect the product. Protect from light. Avoid excessive heat and protect from freezing. Single dose container. Additives should not be added or infused through the same intravenous line. The overwrap is a moisture barrier. Do not remove unit from overwrap until ready to use. Use unit promptly when pouch is open. After removing the overwrap, check for minute leaks by squeezing container firmly. If leaks are found, discard unit as sterility may be impaired. Use only if solution is clear and container is undamaged. DISCARD UNUSED PORTION. Must not be used in series connections. Rx Only NDC 0143-9720-01
(click image for full-size original)

SERIALIZATION IMAGE

LAYOUT 1LAYOUT 1
LEVOFLOXACIN levofloxacin injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0143-9722
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOFLOXACIN (LEVOFLOXACIN ANHYDROUS) LEVOFLOXACIN ANHYDROUS 250 mg in 50 mL
Inactive Ingredients
Ingredient Name Strength
DEXTROSE MONOHYDRATE 2500 mg in 50 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0143-9722-24 24 BAG in 1 CARTON contains a BAG (0143-9722-01)
1 NDC:0143-9722-01 50 mL in 1 BAG This package is contained within the CARTON (0143-9722-24)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091375 09/16/2011
LEVOFLOXACIN levofloxacin injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0143-9721
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOFLOXACIN (LEVOFLOXACIN ANHYDROUS) LEVOFLOXACIN ANHYDROUS 500 mg in 100 mL
Inactive Ingredients
Ingredient Name Strength
DEXTROSE MONOHYDRATE 5000 mg in 100 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0143-9721-24 24 BAG in 1 CARTON contains a BAG (0143-9721-01)
1 NDC:0143-9721-01 100 mL in 1 BAG This package is contained within the CARTON (0143-9721-24)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091375 09/16/2011
LEVOFLOXACIN levofloxacin injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0143-9720
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOFLOXACIN (LEVOFLOXACIN ANHYDROUS) LEVOFLOXACIN ANHYDROUS 750 mg in 150 mL
Inactive Ingredients
Ingredient Name Strength
DEXTROSE MONOHYDRATE 7500 mg in 150 mL
HYDROCHLORIC ACID
SODIUM HYDROXIDE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0143-9720-24 24 BAG in 1 CARTON contains a BAG (0143-9720-01)
1 NDC:0143-9720-01 150 mL in 1 BAG This package is contained within the CARTON (0143-9720-24)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA091375 09/16/2011
Labeler — Hikma Pharmaceuticals USA Inc. (001230762)
Establishment
Name Address ID/FEI Operations
HIKMA FARMACEUTICA (PORTUGAL), S.A 452742943 ANALYSIS (0143-9722), ANALYSIS (0143-9721), ANALYSIS (0143-9720), LABEL (0143-9722), LABEL (0143-9721), LABEL (0143-9720), MANUFACTURE (0143-9722), MANUFACTURE (0143-9721), MANUFACTURE (0143-9720), PACK (0143-9722), PACK (0143-9721), PACK (0143-9720)

Revised: 03/2019 Hikma Pharmaceuticals USA Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.